Daniel Eiras

15 papers receiving 382 citations

Daniel Eiras's Hit Papers

Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons 2025 · 19 citations
190Years since publication51015

Peers

Daniel Eiras
Comparison fields: 5 of 51
  • Applied Microbiology and Biotechnology 66
  • Molecular Medicine 135
  • Pharmacology 55
  • Pharmacology 68
  • Hepatology 29
Replace Liesbet De Bus with:
Liesbet De Bus Belgium
Mary L. Townsend United States
Emmanuel Wey United Kingdom
Khurram Rana United States
Kajal Larson United States
Moon‐Won Kang South Korea
Janet Wu United States
Ariadna Padullés Spain
Young R. Lee United States
Nathalie Baillon-Plot France
Daniel Eiras relative to Liesbet De Bus Belgium Liesbet De Bus's profile →
Citations per field
00.5×4.1×
Liesbet De Bus · 1×
Citations per year

Countries citing papers authored by Daniel Eiras

Since Specialization
Citations

This map shows the geographic impact of Daniel Eiras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Eiras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Eiras more than expected).

Fields of papers citing papers by Daniel Eiras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Eiras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Eiras. The network helps show where Daniel Eiras may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Eiras, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Eiras Line = papers co-authored together Daniel Eiras links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 201671
2 201568
3 200764
4 201849
5 201544
6 201627
7
Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
Hit paper breakdown →
202519
8 201817
9 201011
10 20205
11 20153
12 20152
13 20251
14 20231
15 20161
16 20230
17 20240

About Daniel Eiras

Daniel Eiras is a scholar working on Epidemiology, Pharmacology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Psychiatry and Mental health, having authored 17 papers that have together received 383 indexed citations. Recurring topics across this work include Respiratory viral infections research (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Infection Control and Ventilation (3 papers), Epilepsy research and treatment (3 papers), Trypanosoma species research and implications (2 papers), Antibiotic Use and Resistance (2 papers), Viral Infections and Immunology Research (2 papers) and Research on Leishmaniasis Studies (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (66 citations), Molecular Medicine (135 citations), Pharmacology (55 citations), Pharmacology (68 citations) and Hepatology (29 citations). Daniel Eiras has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include E. Yoko Furuya, David P. Calfee, Angela Loo, Brian Nelson, Christine J. Kubin, Henry W. Murray, Laura A. Kirkman, Angela Gomez‐Simmonds, Stephen G. Jenkins and Michael J. Satlin. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Infection Control and Hospital Epidemiology, Clinical Infectious Diseases and American Journal of Tropical Medicine and Hygiene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact